Clinical Trial Update: Once Daily Accelerated Fractionation With Concomitant Boost to the Gross Tumor Volume Compared With Twice Daily Hyperfractionation in Concurrent Chemoradiation in Patients With Limited Disease Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial comparing once-daily accelerated fractionation with a concomitant GTV boost to twice-daily hyperfractionation in concurrent chemoradiation for lim…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Limited-stage Small Cell Lung Cancer

Snippet

Sponsor: National Cancer Center, Korea | Conditions: Limited Disease Small Cell Lung Cancer | Phase 2 | Status: UNKNOWN